Wall Street analysts will be watching closely when Elanco Animal Health Incorporated (NYSE:ELAN) reports its quarterly earnings next, which is scheduled for Wed 1 May (In 15 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $0.26 per share. In the preceding quarter, the company reportedly generated EPS of $0.29 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of , a profit margin of and a gross margin of 48.70%.
Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of Elanco Animal Health Incorporated (NYSE:ELAN). Most recently, on March 18th, 2019, BofA/Merrill Upgrade a Buy rating. Before that, on March 13th, 2019, Morgan Stanley Resumed to Equal-Weight. William Blair Initiated a Mkt Perform rating on February 12th, 2019, UBS Initiated an Sell rating on January 23rd, 2019, and Argus Initiated a Buy rating on January 15th, 2019.
At its current price point, combined with the fact that this company has 365.64M shares outstanding, the current market capitalization sits at 11.62B. In the last trading day, 2,453,194 shares of Elanco Animal Health Incorporated were traded, which compares to its usual volume of about 10.22M shares per day of trading.
If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by -$0.98 in the past five trading days, resulting in a percentage change of -2.99% and a moving average of 32.28. In the past 20 days, its price changed by -$1.05 (which is -3.20%) and the stock’s moving average was 32.59. Looking back a full 50 days, shares of ELAN changed by $2.13 (which is +7.18%) and demonstrated a moving average of 31.05.
Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 16.76%, a 14-day Stochastic %K score of 26.18% and a 20-day Stochastic %K score of 32.56%. Using a similar metric, Elanco Animal Health Incorporated (ELAN) shares showed a Stochastic %D of 24.50% over the past 9 days, a Stochastic %D score of 35.78% over the last 14 days, and a 20-day Stochastic %D of 51.77%. Meanwhile, this stock’s MACD Oscillator was -0.47 over the past 9 days, -0.38 over the past two weeks, and -0.42 in the last 20 days.
As recent trading data suggests, this company’s shares have been hovering close to the $31.78 level. Over the past 12 months, this stock has experienced a high price of $37.61 and a low of $28.00. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.
Morgan Stanley Investment Managem sold more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from Elanco Animal Health Incorporated (NYSE:ELAN) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 8,873,797 shares of the company’s stock following the subtraction of -45,728 to this investor’s holdings during the three-month period. This share count represents that Morgan Stanley Investment Managem now held 2.43% stake in Elanco Animal Health Incorporated (ELAN)’s shares.
Just in the most recent trading day, Elanco Animal Health Incorporated (NYSE:ELAN) experienced a high price of $32.50 and low point of $31.71. At the end of the last trading session, this stock was at 31.78 per share, following a loss of -$32.14, or -1.12% during the full day.